Alaunos Therapeutics, Inc. Annual Interest Expense in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Alaunos Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2021 to 2023.
  • Alaunos Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Alaunos Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Alaunos Therapeutics, Inc. annual Interest Expense for 2023 was $1.92M, a 39.1% decline from 2022.
  • Alaunos Therapeutics, Inc. annual Interest Expense for 2022 was $3.15M, a 165% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.92M -$1.23M -39.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $3.15M +$1.97M +165% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $1.19M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.